SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-068457
Filing Date
2023-03-13
Accepted
2023-03-13 07:05:30
Documents
14
Period of Report
2023-03-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d469662d8k.htm   iXBRL 8-K 33183
2 EX-99.1 d469662dex991.htm EX-99.1 10506
6 GRAPHIC g469662g0313003403064.jpg GRAPHIC 3402
  Complete submission text file 0001193125-23-068457.txt   176898

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA obsv-20230310.xsd EX-101.SCH 2847
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE obsv-20230310_lab.xml EX-101.LAB 17926
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE obsv-20230310_pre.xml EX-101.PRE 11235
8 EXTRACTED XBRL INSTANCE DOCUMENT d469662d8k_htm.xml XML 3389
Mailing Address CHEMIN DES AULX, 12 PLAN-LES-OUATES V8 1228
Business Address CHEMIN DES AULX, 12 PLAN-LES-OUATES V8 1228 0041-0-22-552-1558
ObsEva SA (Filer) CIK: 0001685316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37993 | Film No.: 23725669
SIC: 2834 Pharmaceutical Preparations